Clinical Trials Directory

Trials / Completed

CompletedNCT03884023

Effect of REST in the Alzheimer Disease Continuum

Effect of REST on Cognitive Function and Hippocampus in the Alzheimer Disease Continuum

Status
Completed
Phase
Study type
Observational
Enrollment
300 (actual)
Sponsor
Dongzhimen Hospital, Beijing · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The investigators assume that REST gene polymorphism affects REST protein concentration, and REST protein concentration in peripheral blood is related to cognitive function and hippocampus. In this current study, REST protein content and gene polymorphism will be obtained in peripheral blood in AD and normal control. The effect of REST gene polymorphism on REST protein concentration will be discovered.The relationship between REST protein concentration and cognitive function will be found, as well as the relationship between REST protein concentration and hippocampus.

Detailed description

Repressor element silencing transcription factor(REST), also known as neuron-restrictive silencer factor (NRSF) is a zinc finger protein of 121 kD and belongs to the Gli-Kruppel family with transcriptional regulation.This will be a Case-Crossover research. Consecutive participants will be divided into Alzheimer's disease dementia group, mild cognitive impairment due to Alzheimer's disease group and normal control group according to inclusion criteria of this research. Peripheral blood samples will be retained to detect REST gene polymorphisms and protein concentrations. Participants perform neuropsychological tests to assess cognitive function. Medial temporal atrophy scale is used to describe hippocampus. Differences in the mean or proportions between these 3 groups will be checked by t test or test. The relationship between REST protein concentration and cognitive function will be estimated, as well as the relationship between REST protein concentration and hippocampus.

Conditions

Timeline

Start date
2019-06-28
Primary completion
2020-11-30
Completion
2020-11-30
First posted
2019-03-21
Last updated
2022-03-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03884023. Inclusion in this directory is not an endorsement.